Viewing Study NCT01143402

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-06-17 @ 5:43 PM
Study NCT ID: NCT01143402
Status: COMPLETED
Last Update Posted: 2017-07-26
First Post: 2010-06-11
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Iris Melanoma View
None Medium/Large Size Posterior Uveal Melanoma View
None Ocular Melanoma With Extraocular Extension View
None Recurrent Uveal Melanoma View
None Small Size Posterior Uveal Melanoma View
None Stage IV Uveal Melanoma View
Keywords: